TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 9, 2012 | $290,000 | Replaced |
| 2nd Quarter - Amendment (this page) | May 27, 2015 | $290,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
S. 3187, the Food and Drug Administration (FDA) Safety and Innovation Act of 2012; Drug Import Safety issues; foreign drug supply chain issues; counterfiet drugs, serialization and development of tracibility model
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER | — |
| ANDREA WILKINSON | — |
Trade (domestic/foreign) TRD
Importation issues; Preserve Access to Affordable Generics Act; S. 319 Pharmaceutical Market Access and Drug Safety Act; Drug Import Safety issues; foreign drug supply chain issues; counterfiet drugs, serialization and development of tracibility model
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER | — |
| ANDREA WILKINSON | — |
Health Issues HCR
health reform and the un/underinsured and implications of ACA SCOTUS decision; chronic disease legislation (diabetes, mental health, obesity, CKD); value based insurance design, quality of care, adhereance, ACA implementation; Anit-Gout USP matters; HR 5 IPAB repeal;
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| DEBORAH LYNN WALTER | — |
| ANDREA WILKINSON | — |
Medicare/Medicaid MMM
Implications of ACA and Supreme Court decision; depression Rx access in Medicare, Medicaid, DOD, VA; lack of obesity Rx access in Part D;
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| DEBORAH LYNN WALTER | — |
| ANDREA WILKINSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.